17:19 EST Sana Biotechnology (SANA) up 285% afterhours following type 1 diabetes study data
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SANA:
- Sana Biotechnology announces initial results from type 1 diabetes study
- Sana Biotechnology price target lowered to $7 from $8 at BofA
- Sana Biotechnology announces Fast Track designation for SC291
- Climb Bio appoints Williams as Chair of the board of directors
- Sana Biotechnology, Inc. Reports Q3 2024 Financial Results